Transglutaminase: New insights into gelatin nanoparticle cross-linking

Journal of Microencapsulation

Volumn 27, Issue 8, 2010, Pages 747-754

  Fuchs, S ^a   Kutscher, M ^a   Hertel, T ^b   Winter, G ^a   Pietzsch, M ^b   Coester, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cross linking; Drug delivery; Gelatin; Nanoparticle; Stability

Indexed keywords

GELATIN; GELATIN NANOPARTICLE; NANOPARTICLE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; INCUBATION TIME; PARTICLE SIZE; PH; PROTEIN CROSS LINKING; TEMPERATURE; TURBIDITY;

ACETONE; ANIMALS; CATALYSIS; CROSS-LINKING REAGENTS; DRUG STABILITY; DRUG STORAGE; ESCHERICHIA COLI; GELATIN; GLUTARAL; NANOPARTICLES; NEPHELOMETRY AND TURBIDIMETRY; PARTICLE SIZE; SOLVENTS; SWINE; TEMPERATURE; TRANSGLUTAMINASES;

EID: 78049461954     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.518773     Document Type: Article

References (35)

1. Aimi M, Nemori R, Kojima M, Kishima M. 2006. Protein nanoparticles for drug delivery. Fujifilm Corporation, Japan. 2006-JP325987[2007072982], WO 20070628.
2. Aimi M, Nemori R, Miyashita Y, Yokoyama H. 2007. Enzymatically crosslinked protein nanoparticles. Fujifilm Corporation, Japan. 2007- JP51856[2007086613], 26, 20070802.
3. Bae HJ, Darby D, Kimmel R, Park HJ, Whiteside W. Effects of transglutaminase- induced cross-linking on properties of fish gelatin-nanoclay composite film. Food Chem, 2009;114 (1):180-9.
4. Ballantyne B, Jordan SL. Toxicological, medical, and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures. J Appl Toxicol, 2001;21 (2):131-51.
5. Barbetta A, Massimi M, Devirgiliis LC, Dentini M. Enzymatic cross-linking versus radical polymerization in the preparation of gelatin polyHIPEs and their performance as scaffolds in the culture of hepatocytes.Biomacromolecules, 2006;7 (11):3059-68.
6. Bertoni F, Barbani N, Giusti P, Ciardelli G. Transglutaminase reactivity with gelatine: Perspective applications in tissue engineering. Biotechnol Lett, 2006;28 (10):697-702.
7. Besheer A, Hertel TC, Kressler J, Maeder K, Pietzsch M. Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility. J Pharm Sci, 2009;98 (11):4420-8.
8. Boenisch MP, Huss M, Weitl K, Kulozik U. Transglutaminase cross-linking of milk proteins and impact on yoghurt gel properties. Int Dairy J, 2007;17 (11):1360-71.
9. Bourquin C, Anz D, Zwiorek K, Lanz AL, Fuchs S, Weigel S, Wurzenberger C, von der Borch P, Golic M, Moder S, et al. Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity. J Immunol, 2008;181 (5):2990-8.
10. Broderick EP, OHalloran DM, Rochev YA, Griffin M, Collighan RJ, Pandit AS. Enzymatic stabilization of gelatin-based scaffolds. J Biomed Mater Res B Appl Biomater, 2005;72 (1):37-42.
11. Chau DYS, Collighan RJ, Verderio EAM, Addy VL, Griffin M. The cellular response to transglutaminase-cross-linked collagen. Biomaterials, 2005;26 (33):6518-29.
12. Coester C. Development of a new carrier system for oligonucleotides and plasmids based on gelatin nanoparticles. New Drugs, 2003;1: 14-17.
13. Coester CJ, Langer K, Von Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsul, 2000;17 (2):187-93.
14. Collighan RJ, Griffin M. Transglutaminase 2 cross-linking of matrix proteins: Biological significance and medical applications. Amino Acids, 2009;36 (4):659-70.
15. Cui L, Du G, Zhang D, Fan X, Chen J. Stability and conformational changes of transglutaminase from Streptomyces hygroscopicus in ethanol-aqueous medium. Process Biochem, (Amsterdam, The Netherlands), 2008;43 (8):887-91.
16. de Carvalho RA, Grosso CRF. Characterization of gelatin based films modified with transglutaminase, glyoxal and formaldehyde. Food Hydrocoll, 2004;18 (5):717-26.
17. Folk JE, Cole PW. Transglutaminase: Mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim Biophys Acta, 1966;122:244-64.
18. Fraunhofer W, Winter G, Coester C. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems. Anal Chem, 2004;76 (7):1909-20.
19. Fuchs S, Winter G, Coester C. Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles. J Microencapsul, 2010;27 (3):242-52.
20. Griffin M, Casadio R, Bergamini CM. Transglutaminases: Natures biological glues. Biochem J, 2002;368 (2):377-96.
21. Heidebach T, Foerst P, Kulozik U. Transglutaminase-induced caseinate gelation for the microencapsulation of probiotic cells. Int Dairy J, 2008;19 (2):77-84.
22. Lantto R. Protein cross-linking with oxidative enzymes and transglutaminase. Effects in meat protein systems. VTT Publ, 2007;642:1-114.
23. Marx CK, Hertel TC, Pietzsch M. Soluble expression of a pro-transglutaminase from Streptomyces mobaraensis in Escherichia coli. Enzyme Microb Technol, 2007;40 (6):1543-50.
24. Marx CK, Hertel TC, Pietzsch M. Purification and activation of a recombinant histidine-tagged pro-transglutaminase after soluble expression in Escherichia coli and partial characterization of the active enzyme. Enzyme Microb Technol, 2008;42 (7):568-75.
25. Plishker MF, Thorpe JM, Goldsmith LA. Human epidermal transglutaminase: Stimulation by trypsin, organic solvents, and chaotropic salts. Arch Biochem Biophys, 1978;191 (1):49-58.
26. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J, 2007;9 (2):E128-47.
27. Van Luyn MJA, Van Wachem PB, Dijkstra PJ, Olde Damink LHH, Feijen J. Calcification of subcutaneously implanted collagens in relation to cytotoxicity, cellular interactions and crosslinking. J Mater Sci Mater Med, 1995;6 (5):288-96.
28. Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterization of protein nanoparticles. Int J of Pharmaceuticals, 2000;194 (1):91-102.
29. Wilms B, Hauck A, Reuss M, Syldatk C, Mattes R, Siemann M, Altenbuchner J. High-cell-density fermentation for production of L-Ncarbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. Biotechnol Bioeng, 2001;73 (2):95-103.
30. Yoon JH, McKenzie D. A comparison of the activities of three betagalactosidases in aqueous-organic solvent mixtures. Enzyme Microb Technol, 2005;36 (4):439-46.
31. Zhu Y, Tramper J. Novel applications for microbial transglutaminase beyond food processing. Trends Biotechnol, 2008;26 (10):559-65.
32. Zillies JC, Zwiorek K, Winter G, Coester C. Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection. Anal Chem, 2007;79 (12):4574-80.
33. Zwiorek K. 2006. Gelatin nanoparticles as delivery system for nucleotidebased drugs. Thesis, Ludwig Maximilians University, Munich.
34. Zwiorek K, Bourquin C, Battiany J, Winter G, Endres S, Hartmann G, Coester C. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG ligonucleotides. Pharm Res, 2008;25 (3):551-62.
35. Zwiorek K, Kloeckner J, Wagner E, Coester C. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci, 2004;7 (4):22-8.